Opportunity
DIBBS #SPE2DP-26-T-2923
DLA Procurement of Meloxicam Tablets for Fort Campbell
Posted
April 16, 2026
Respond By
April 21, 2026
Identifier
SPE2DP-26-T-2923
NAICS
424210
This procurement opportunity from the Defense Logistics Agency (DLA) seeks Meloxicam Tablets for military medical supply: - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - OEMs (Approved Manufacturers): - EXELAN PHARMACEUTICALS INC (part number NDC76282-0153-01) - ZYDUS PHARMACEUTICALS (USA) INC. (part number NDC68382-0051-01) - XLCARE PHARMACEUTICALS INC (part number NDC72865-0138-01) - Vendors: No specific resellers named; only OEMs listed as approved sources - Products Requested: - Meloxicam Tablets, 15 mg, 100-count bottles - NSN: 6505-01-541-3243 - Total quantity: 6 bottles (2 in one line item, 4 in another) - Part numbers as above, corresponding to each OEM - Unique/Notable Requirements: - Delivery to Fort Campbell, KY (military base) - Packaging and marking must comply with Medical Marking Standard No. 1 and MIL-STD-2073-1E - Compliance with Buy American Act - Hazardous material labeling required - Cybersecurity requirements per NIST SP 800-171 - Delivery required within 20 calendar days from award (FOB destination) - No option years or recurring subscription; one-time delivery - DLA is the contracting office and buyer
Description
MELOXICAM TABLETS (QTY: 4, NSN: 6505-01-541-3243, Purchase Request: 7016334554) Approved Sources: - CAGE: 6GFC4, Part No: NDC76282-0153-01, Company: EXELAN PHARMACEUTICALS INC - CAGE: 6YA44, Part No: NDC68382-0051-01, Company: ZYDUS PHARMACEUTICALS (USA) INC. - CAGE: 86SL9, Part No: NDC72865-0138-01, Company: XLCARE PHARMACEUTICALS INC
MELOXICAM TABLETS (QTY: 2, NSN: 6505-01-541-3243, Purchase Request: 7016334553) Approved Sources: - CAGE: 6GFC4, Part No: NDC76282-0153-01, Company: EXELAN PHARMACEUTICALS INC - CAGE: 6YA44, Part No: NDC68382-0051-01, Company: ZYDUS PHARMACEUTICALS (USA) INC. - CAGE: 86SL9, Part No: NDC72865-0138-01, Company: XLCARE PHARMACEUTICALS INC